15 Recruiting Acute Myeloid Leukemia, in Relapse Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Acute Myeloid Leukemia, in Relapse Studies
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
📍 Novant Health Cancer Institute — Charlotte, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Venetoclax to Augment Epigenetic Modification and Chemotherapy
📍 Children's Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)
📍 Scripps Green Hospital — La Jolla, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
📍 University of Virginia Cancer Center — Charlottesville, Virginia
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
📍 City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Interventional Protocol 📊 Observational Clinical Research
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
📍 Novant Health Cancer Institute — Charlotte, North Carolina
View Study & Checklist ➔